awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47148072-5DD3DBCD-4028-44FA-ABB4-41073F4C75AF
Q47148072-5DD3DBCD-4028-44FA-ABB4-41073F4C75AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47148072-5DD3DBCD-4028-44FA-ABB4-41073F4C75AF
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
P2860
Q47148072-5DD3DBCD-4028-44FA-ABB4-41073F4C75AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47148072-5DD3DBCD-4028-44FA-ABB4-41073F4C75AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e02296f029d40e920c511e02b70c7d0f9048be35
P2860
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.